Phrommintikul Arintaya, Nathisuwan Surakit, Wongcharoen Wanwarang, Krittayaphong Rungroj, Gunaparn Siriluck, Wongthanee Antika, Mathers Jonathan, Jowett Sue, Jolly Kate, Lane Deirdre A, Thomas G Neil, Lip Gregory Y H
Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
JACC Asia. 2024 Oct 8;5(1):205-213. doi: 10.1016/j.jacasi.2024.08.011. eCollection 2025 Jan.
An educational-behavioral intervention has been shown to improve anticoagulation control with warfarin in atrial fibrillation (AF) patients, but widespread application may not be practical. The SAMe-TTR score was formulated to identify the likelihood of achieving optimal time in therapeutic range (TTR).
The authors conducted a randomized controlled trial to evaluate the impact of a SAMe-TTR score-guided strategy for an educational-behavioral intervention, compared with usual care on patient's anticoagulation control.
Anticoagulant-naive adult AF patients were randomized to a SAMe-TTR score-guided strategy or usual care. In the SAMe-TTR score-guided strategy group, scores 0 to 2 received usual care, >2 received educational-behavioral intervention plus usual care. All received warfarin targeting international normalized ratio 2.0 to 3.0. Primary outcome was TTR at 12 months. Secondary outcomes included TTR at 6 months, thromboembolic and bleeding events, major adverse cardiovascular events at 12 months, and change in AF knowledge at 6 and 12 months.
A total of 320 patients (mean age 69.5 years; 48.8% female) were randomized to a SAMe-TTR score-guided strategy plus usual care (n = 156) or usual care alone (n = 164). Mean CHADS-VASc score and SAMe-TTR score were 3.1 ± 1.4 and 3.3 ± 0.9, respectively. At 12 months, mean TTR was not significantly different between groups (41.0 [95% CI: 36.7-45.2] in the SAMe-TTR score-guided strategy vs 40.2 [95% CI: 35.9-44.4] with usual care, and the difference between the 2 groups was 0.7 [95% CI: -5.2 to 6.6]). There were no significant differences in secondary outcomes.
SAMe-TTR score-guided strategy for an educational-behavioral intervention, compared with usual care did not significantly improve outcomes over 12 months. (A prospective randomised trial examining the impact of an intensive educational intervention versus usual care on anticoagulation therapy control based on SAMe-TTR score guided strategy in anticoagulant-naive Thai patients with atrial fibrillation; TCTR20180711003).
一项教育行为干预已被证明可改善心房颤动(AF)患者使用华法林的抗凝控制,但广泛应用可能并不实际。制定了SAME-TTR评分以确定达到治疗范围内最佳时间(TTR)的可能性。
作者进行了一项随机对照试验,以评估SAME-TTR评分指导的教育行为干预策略与常规护理相比对患者抗凝控制的影响。
未接受过抗凝治疗的成年AF患者被随机分为SAME-TTR评分指导策略组或常规护理组。在SAME-TTR评分指导策略组中,评分0至2的患者接受常规护理,评分>2的患者接受教育行为干预加常规护理。所有患者均接受目标国际标准化比值为2.0至3.0的华法林治疗。主要结局是12个月时的TTR。次要结局包括6个月时的TTR、血栓栓塞和出血事件、12个月时的主要不良心血管事件以及6个月和12个月时AF知识的变化。
共有320例患者(平均年龄69.5岁;48.8%为女性)被随机分为SAME-TTR评分指导策略加常规护理组(n = 156)或单纯常规护理组(n = 164)。平均CHADS-VASc评分为3.1±1.4,SAME-TTR评分为3.3±0.9。12个月时,两组的平均TTR无显著差异(SAME-TTR评分指导策略组为41.0 [95%CI:36.7 - 45.2],常规护理组为40.2 [95%CI:35.9 - 44.4],两组之间的差异为0.7 [95%CI:-5.2至6.6])。次要结局无显著差异。
与常规护理相比,SAME-TTR评分指导的教育行为干预策略在12个月内未显著改善结局。(一项前瞻性随机试验,研究强化教育干预与常规护理对未接受过抗凝治疗的泰国房颤患者基于SAME-TTR评分指导策略的抗凝治疗控制的影响;TCTR20180711003)